NASDAQ:LEGN
Legend Biotech
- Stock
Last Close
46.37
17/05 20:00
Market Cap
10.28B
Beta: −0.08
Volume Today
564.55K
Avg: 810.09K
PE Ratio
−39.80
PFCF: −29.36
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 1.15M - | 1.48M 29.01% | 1.77M 20.02% | 6.05M 241.03% | 14.89M 146.11% | ||
average payables | 8.45M - | 7.41M 12.32% | 6.14M 17.15% | 19.97M 225.19% | 26.53M 32.85% | ||
average receivables | 72.16M - | 60.37M 16.34% | 74.07M 22.70% | 31.63M 57.30% | 50.07M 58.30% | ||
book value per share | 0.09 - | -1.23 1,520.62% | 2.37 293.46% | 3.35 41.04% | 4.68 39.89% | 7.11 51.85% | |
capex per share | -0.21 - | -0.39 86.34% | -0.42 7.78% | -0.33 20.61% | -0.14 58.13% | ||
capex to depreciation | -12.49 - | -7.44 40.40% | -5.01 32.68% | -3.39 32.45% | -1.21 64.22% | ||
capex to operating cash flow | -0.07 - | 0.47 790.21% | 0.22 52.67% | 0.24 6.35% | 0.11 53.09% | ||
capex to revenue | -0.43 - | -0.68 59.88% | -0.66 3.84% | -0.52 20.23% | -0.19 63.72% | ||
cash per share | 2.16 - | 1.59 26.49% | 4.28 169.88% | 6.26 46.37% | 6.45 2.94% | 7.43 15.28% | |
days of inventory on hand | 57.82 - | 49.18 14.93% | |||||
days payables outstanding | 183.68 - | 51.02 72.22% | |||||
days sales outstanding | 806.53 - | 227.91 71.74% | 409.90 79.85% | 256.76 37.36% | 0.28 99.89% | 128.06 45,511.80% | |
debt to assets | 0.01 - | 0.02 110.19% | 0.00 77.88% | 0.11 2,250.30% | 0.21 94.43% | 0.15 28.01% | |
debt to equity | 0.50 - | -0.05 109.92% | 0.01 124.30% | 0.26 2,068.26% | 0.38 46.49% | 0.23 40.53% | |
dividend yield | |||||||
earnings yield | -0.00 - | -0.04 4,676.29% | -0.09 154.34% | -0.06 35.50% | -0.06 4.43% | -0.05 12.99% | |
enterprise value | 3.50B - | 3.63B 3.67% | 2.87B 20.82% | 6.00B 108.68% | 7.44B 23.98% | 9.65B 29.68% | |
enterprise value over ebitda | -487.95 - | -28.90 94.08% | -9.48 67.22% | -15.82 67.01% | -17.00 7.45% | -21.81 28.28% | |
ev to operating cash flow | 11.38 - | -43.71 484.01% | -12.89 70.51% | -30.23 134.48% | -37.18 23.01% | ||
ev to sales | 71.28 - | 63.40 11.05% | 37.99 40.08% | 66.81 75.87% | 63.57 4.85% | 33.83 46.79% | |
free cash flow per share | 2.86 - | -1.22 142.64% | -2.31 89.28% | -1.74 24.48% | -1.40 19.83% | ||
free cash flow yield | 0.08 - | -0.03 142.64% | -0.08 148.69% | -0.04 54.37% | -0.03 25.15% | ||
graham net net | -1.22 - | -2.24 83.49% | 1.10 149.00% | 2.01 83.52% | 2.79 38.79% | 4.57 63.44% | |
graham number | 0.23 - | 6.05 2,504.86% | 11.71 93.52% | 14.37 22.70% | 17.19 19.66% | 21.69 26.20% | |
income quality | -190.40 - | 0.64 100.33% | 0.72 13.78% | 0.51 29.11% | 0.45 12.67% | ||
intangibles to total assets | 0.00 - | 0.02 15,570.01% | 0.00 77.90% | 0.00 5.88% | 0.00 38.85% | 0 100% | |
interest coverage | -18.71 - | -586.87 3,037.09% | -74.45 87.31% | -436.69 486.59% | -42.22 90.33% | -20.29 51.94% | |
interest debt per share | 0.04 - | 0.06 43.40% | 0.06 1.95% | 0.88 1,270.41% | 1.86 111.16% | 1.74 6.32% | |
inventory turnover | 6.31 - | 7.42 17.56% | |||||
invested capital | 0.50 - | -0.05 109.92% | 0.01 124.30% | 0.26 2,068.26% | 0.38 46.49% | 0.23 40.53% | |
market cap | 3.71B - | 3.71B 0% | 3.33B 10.27% | 6.57B 97.32% | 7.94B 20.93% | 10.59B 33.45% | |
net current asset value | -93.44M - | -203.48M 117.76% | 152.11M 174.75% | 301.59M 98.28% | 512.47M 69.92% | 907.87M 77.16% | |
net debt to ebitda | 28.68 - | 0.62 97.85% | 1.49 142.31% | 1.49 0.14% | 1.15 23.21% | 2.15 87.27% | |
net income per share | -0.03 - | -1.33 4,676.29% | -2.57 93.57% | -2.74 6.75% | -2.81 2.35% | -2.94 4.87% | |
operating cash flow per share | 3.07 - | -0.83 127.00% | -1.89 127.71% | -1.41 25.35% | -1.26 10.74% | ||
payables turnover | 1.99 - | 7.15 259.99% | |||||
receivables turnover | 0.45 - | 1.60 253.87% | 0.89 44.40% | 1.42 59.64% | 1.30K 91,352.14% | 2.85 99.78% | |
research and ddevelopement to revenue | 1.23 - | 2.83 129.15% | 3.07 8.48% | 3.49 13.75% | 2.87 17.80% | 1.34 53.27% | |
return on tangible assets | -0.01 - | -0.47 7,151.47% | -0.42 10.20% | -0.35 17.94% | -0.34 3.05% | -0.28 16.62% | |
revenue per share | 0.49 - | 0.57 16.55% | 0.64 12.09% | 0.64 0.47% | 0.74 15.40% | 1.62 120.12% | |
roe | -0.32 - | 1.08 436.21% | -1.08 200.06% | -0.82 24.31% | -0.60 26.83% | -0.41 30.94% | |
roic | -0.15 - | 1.21 888.58% | -1.08 189.32% | -0.66 38.84% | -0.43 34.15% | -0.28 35.70% | |
sales general and administrative to revenue | 0.06 - | 0.12 109.22% | 0.31 159.41% | 0.52 70.91% | 0.69 31.83% | ||
shareholders equity per share | 0.09 - | -1.23 1,520.62% | 2.37 293.46% | 3.35 41.04% | 4.68 39.89% | 7.11 51.85% | |
stock based compensation to revenue | 0.01 - | 0.02 55.03% | 0.06 183.17% | 0.22 256.91% | 0.29 30.73% | ||
tangible asset value | 8.60M - | -128.02M 1,588.58% | 277.40M 316.69% | 466.52M 68.17% | 740.90M 58.81% | 1.26B 69.88% | |
tangible book value per share | 0.09 - | -1.28 1,588.58% | 2.35 283.79% | 3.31 41.07% | 4.66 40.65% | 7.15 53.44% | |
working capital | 167.77M - | 79.34M 52.71% | 431.69M 444.08% | 668.49M 54.85% | 801.33M 19.87% | 1.28B 59.91% |
All numbers in USD (except ratios and percentages)